News Search

“I hope that our study raises awareness that even a brief exposure to these addictive medications for surgery-related pain or anxiety can lead to long-term use,” says first author Dr. Jacob C. Cogan.

In our Disruptors column, Gordana Vunjak-Novakovic discusses groundbreaking work between engineers and cancer researchers to accelerate personalized therapeutics and better understand the disease.

Dr. James Church weighs in on the significance of this sweeping change in screening guidelines for colorectal cancer.

Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.